MPSYF - I-Mab gains FDA breakthrough tag for kidney disease therapy
2023-11-02 10:07:57 ET
More on I-Mab, Morphic, etc.
- Morphic Holding: The Price Drop Is Very Interesting
- I-Mab: Why This Company Trades At A Third The Value Of Its Cash
- I-Mab (IMAB) Q2 2023 Earnings Call Transcript
- MorphoSys expects a 5% surge in Monjuvi sales for Q3
- Biggest stock movers today: Cloudflare, NextEra Energy Partners, ChargePoint and more
For further details see:
I-Mab gains FDA breakthrough tag for kidney disease therapy